News
-
-
-
-
COMMUNIQUÉ DE PRESSE
Catheter Precision, Inc. (NYSE American:VTAK) Announces the First use of VIVO in Qatar
Catheter Precision, Inc. announces the groundbreaking use of VIVO in electrophysiology procedures at Hamad Medical Corporation Heart Hospital in Qatar, with focus on streamlining workflow and expanding in the Middle East -
-
-
COMMUNIQUÉ DE PRESSE
Catheter Precision, Inc. (NYSE American: VTAK) Announces the First use of LockeT Outside of the United States
Catheter Precision, Inc. announced the first successful use of LockeT outside the United States at Hamad Medical Corporation Heart Hospital in Doha, Qatar, receiving positive feedback from Dr. Sajad Hayat and CEO David Jenkins -
-
-
COMMUNIQUÉ DE PRESSE
Catheter Precision, Inc. (NYSE American:VTAK) Announces the First Use of VIVO With a Pediatric Patient in Turkey
Catheter Precision, Inc. announced the use of VIVO for the first time on a pediatric patient in Turkey, showcasing the benefits of the innovative non-invasive 3D imaging system for pre-procedure planning in electrophysiology
